Eden Research (LON:EDEN) Releases Quarterly Earnings Results

Eden Research (LON:EDEN) posted its quarterly earnings data on Tuesday. The company reported GBX (0.36) ($0.00) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 38.70% and a negative return on equity of 11.63%.

Eden Research Trading Down 5.6 %

Shares of Eden Research stock opened at GBX 2.69 ($0.04) on Wednesday. The firm’s 50-day moving average price is GBX 2.82 and its two-hundred day moving average price is GBX 3.47. Eden Research has a 12-month low of GBX 2.23 ($0.03) and a 12-month high of GBX 5 ($0.07). The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The company has a market capitalization of £14.35 million, a price-to-earnings ratio of -9.42 and a beta of 0.92.

Insider Buying and Selling

In other news, insider Sean M. Smith acquired 426,986 shares of the business’s stock in a transaction that occurred on Tuesday, April 1st. The shares were bought at an average price of GBX 234 ($3.12) per share, with a total value of £999,147.24 ($1,334,153.08). Also, insider Alexander John Abrey acquired 167,947 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The stock was bought at an average price of GBX 3 ($0.04) per share, with a total value of £5,038.41 ($6,727.75). In the last 90 days, insiders have bought 850,933 shares of company stock worth $101,442,565. Corporate insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.